29 computer-programmer-"https:"-"CEA-Saclay"-"https:" research jobs at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
Astronautics! We are seeking a talented and motivated Research Fellow to contribute to a fully-funded project focused on advancing the computational analysis and manufacturing of these critical materials. Who
-
(R3) Country United Kingdom Application Deadline 16 Oct 2025 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU
-
We are seeking a highly motivated Research Fellow to join the School of Electronics and Computer Science (ECS) at University of Southampton for a two-year position in the area of Personalised
-
We are seeking a highly motivated and skilled Research Fellow to join the Cancer Data-Driven Detection (CD3) programme. CD3 is a new, multidisciplinary and multi-institutional strategic national
-
The University of Southampton is inviting applications for a postdoctoral position in gravitational-wave astronomy. The successful candidate will join Greg Ashton’s STFC-funded programme, Advancing
-
. The successful candidate will work part time as clinical research fellow supporting Professor Clark in his NIHR funded research programme on rapid diagnostic tests. The University of Southampton, Faculty
-
also include planning for the dissemination and implementation of the tool. There will be opportunities to contribute to other elements of the research programme subject to capacity and competencies
-
An exciting opportunity has arisen for a Research Fellow to work on a NIHR ARC Wessex adopted and NIHR PGfAR funded programme grant: Personalised social and self-management support for better living
-
to combine structural biology with the latest advances in computational protein science, shaping ambitious programmes that bridge fundamental discovery with translational application. The postholder will join
-
the laboratory of Professors Ward and Ober. Their interdisciplinary research program is dedicated to the development of novel antibody-based therapeutics that has led to several therapeutics that are currently in